Anticoagulation in a Neurosurgical Patient with Heparin-Induced Thrombocytopenia Type II with Argatroban and Fondaparinux after Clipping of an Intracranial Aneurysm

被引:3
|
作者
Kerz, Thomas [1 ]
Schinzel, Helmut [2 ]
机构
[1] Johannes Gutenberg Univ Mainz, Sch Med, Dept Neurosurg, Mainz, Germany
[2] Johannes Gutenberg Univ Mainz, Sch Med, Med Clin & Policlin 2, Mainz, Germany
关键词
Heparin-induced thrombocytopenia; HIT II; Neurosurgery; Argatroban; Fondaparinux;
D O I
10.1159/000205964
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Therapeutic anticoagulation in patients after a major neurosurgical procedure remains critical because of the risk of a major intracranial bleed. Novel drugs could play a beneficial role in this setting. Case Report: We describe a patient with heparin-induced thrombocytopenia type II and pulmonary embolism who was anticoagulated with argatroban and, later, with fondaparinux. No intracranial bleeding was detected when anticoagulation was performed with argatroban and, later, fondaparinux. Conclusion: Both substances could have therapeutic potential in this context.
引用
收藏
页码:141 / 143
页数:3
相关论文
共 50 条
  • [1] Anticoagulation with argatroban in a parturient with heparin-induced thrombocytopenia
    Ekbatani, A.
    Asaro, L. R.
    Malinow, A. M.
    INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA, 2010, 19 (01) : 82 - 87
  • [2] Excessive argatroban anticoagulation for heparin-induced thrombocytopenia
    Reichert, MG
    MacGregor, DA
    Kincaid, EH
    Dolinski, SY
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (05) : 652 - 654
  • [3] Comparison of argatroban and fondaparinux for the management of patients with isolated heparin-induced thrombocytopenia
    Al-Eidan, Fahad A. S.
    Alrawkan, Saud
    Alshammary, Huda
    Crowther, Mark A.
    ANNALS OF HEMATOLOGY, 2018, 97 (11) : 2055 - 2059
  • [4] Comparison of argatroban and fondaparinux for the management of patients with isolated heparin-induced thrombocytopenia
    Fahad A. S. Al-Eidan
    Saud Alrawkan
    Huda Alshammary
    Mark A. Crowther
    Annals of Hematology, 2018, 97 : 2055 - 2059
  • [5] Argatroban anticoagulation in patients with a history of heparin-induced thrombocytopenia
    Matthai, WH
    Hursting, MJ
    Lewis, BE
    Kelton, JG
    THROMBOSIS RESEARCH, 2005, 116 (02) : 121 - 126
  • [6] Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II
    Wellborn-Kim, Jennifer J.
    Mitchell, George A.
    Terneus, William F., Jr.
    Stowe, Cary L.
    Malias, Mark A.
    Sparkman, Gary M.
    Hanson, Greer W.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (13) : 1075 - 1079
  • [7] Prolonged anticoagulation after discontinuation of argatroban and warfarin therapy in an obese patient with heparin-induced thrombocytopenia
    Shapiro, Nancy L.
    Durr, Emily A.
    Krueger, Courtney D.
    PHARMACOTHERAPY, 2006, 26 (12): : 1806 - 1810
  • [8] Effects of argatroban, danaparoid, and fondaparinux on trombin generation in heparin-induced thrombocytopenia
    Tardy-Poncet, Brigitte
    Combe, Marion
    Piot, Michele
    Chapelle, Celine
    Akrour, Majid
    Tardy, Bernard
    THROMBOSIS AND HAEMOSTASIS, 2013, 109 (03) : 504 - 509
  • [9] Anticoagulation with Novastan® (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome
    Lewis, BE
    Walenga, JM
    Wallis, DE
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1997, 23 (02) : 197 - 202
  • [10] Argatroban Anticoagulation for Heparin-Induced Thrombocytopenia in Elderly Patients
    John R. Bartholomew
    Carolynn E. Pietrangeli
    Marcie J. Hursting
    Drugs & Aging, 2007, 24 : 489 - 499